BindingDB logo
myBDB logout

BDBM82458 BIM 23049::D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH2

SMILES: CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O

InChI Key: InChIKey=CNHZCQXPLDLYRR-XCFOAALMSA-N

Data: 15 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 15 hits for monomerid = 82458   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
5.90n/an/an/an/an/an/an/an/a



McGill University

Curated by PDSP Ki Database




Endocrinology 135: 2814-7 (1994)


Article DOI: 10.1210/endo.135.6.7988476
BindingDB Entry DOI: 10.7270/Q2959G27
More data for this
Ligand-Target Pair
SSTR3


(MOUSE)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

PubMed
10n/an/an/an/an/an/an/an/a



University of Pennsylvania

Curated by PDSP Ki Database




Mol Pharmacol 43: 838-44 (1993)


BindingDB Entry DOI: 10.7270/Q21N7ZN7
More data for this
Ligand-Target Pair
SSTR3


(MOUSE)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
10n/an/an/an/an/an/an/an/a



Sandoz Pharma Ltd

Curated by PDSP Ki Database




Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)


Article DOI: 10.1002/cbic.201402579
BindingDB Entry DOI: 10.7270/Q2XD105R
More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
13.1n/an/an/an/an/an/an/an/a



McGill University

Curated by PDSP Ki Database




Endocrinology 135: 2814-7 (1994)


Article DOI: 10.1210/endo.135.6.7988476
BindingDB Entry DOI: 10.7270/Q2959G27
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
14.3n/an/an/an/an/an/an/an/a



McGill University

Curated by PDSP Ki Database




Endocrinology 135: 2814-7 (1994)


Article DOI: 10.1210/endo.135.6.7988476
BindingDB Entry DOI: 10.7270/Q2959G27
More data for this
Ligand-Target Pair
SSTR2


(MOUSE)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
85.1n/an/an/an/an/an/an/an/a



Sandoz Pharma Ltd

Curated by PDSP Ki Database




Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)


Article DOI: 10.1002/cbic.201402579
BindingDB Entry DOI: 10.7270/Q2XD105R
More data for this
Ligand-Target Pair
SSTR2


(MOUSE)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

PubMed
86n/an/an/an/an/an/an/an/a



University of Pennsylvania

Curated by PDSP Ki Database




Mol Pharmacol 43: 838-44 (1993)


BindingDB Entry DOI: 10.7270/Q21N7ZN7
More data for this
Ligand-Target Pair
SSTR5


(RAT)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
145n/an/an/an/an/an/an/an/a



Sandoz Pharma Ltd

Curated by PDSP Ki Database




Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)


Article DOI: 10.1002/cbic.201402579
BindingDB Entry DOI: 10.7270/Q2XD105R
More data for this
Ligand-Target Pair
SSTR4


(RAT)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

PubMed
146n/an/an/an/an/an/an/an/a



University of Pennsylvania

Curated by PDSP Ki Database




Mol Pharmacol 44: 385-92 (1993)


BindingDB Entry DOI: 10.7270/Q2X065KZ
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3n/an/an/an/an/an/an/an/a



McGill University

Curated by PDSP Ki Database




Endocrinology 135: 2814-7 (1994)


Article DOI: 10.1210/endo.135.6.7988476
BindingDB Entry DOI: 10.7270/Q2959G27
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3n/an/an/an/an/an/an/an/a



Sandoz Pharma Ltd

Curated by PDSP Ki Database




Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)


Article DOI: 10.1002/cbic.201402579
BindingDB Entry DOI: 10.7270/Q2XD105R
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

PubMed
1.00E+3n/an/an/an/an/an/an/an/a



University of Pennsylvania

Curated by PDSP Ki Database




Mol Pharmacol 44: 385-92 (1993)


BindingDB Entry DOI: 10.7270/Q2X065KZ
More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3n/an/an/an/an/an/an/an/a



McGill University

Curated by PDSP Ki Database




Endocrinology 135: 2814-7 (1994)


Article DOI: 10.1210/endo.135.6.7988476
BindingDB Entry DOI: 10.7270/Q2959G27
More data for this
Ligand-Target Pair
SSTR4


(Mus musculus)
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3n/an/an/an/an/an/an/an/a



Sandoz Pharma Ltd

Curated by PDSP Ki Database




Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)


Article DOI: 10.1002/cbic.201402579
BindingDB Entry DOI: 10.7270/Q2XD105R
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM82458
PNG
(BIM 23049 | D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH...)
Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NCc1ccc2ccccc2c1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C52H68N10O9/c1-29(2)44(52(71)57-31(4)48(67)62-45(32(5)63)46(54)65)61-49(68)41(16-10-11-23-53)58-51(70)43(26-37-28-56-40-15-9-8-14-39(37)40)60-50(69)42(25-33-18-21-38(64)22-19-33)59-47(66)30(3)55-27-34-17-20-35-12-6-7-13-36(35)24-34/h6-9,12-15,17-22,24,28-32,41-45,55-56,63-64H,10-11,16,23,25-27,53H2,1-5H3,(H2,54,65)(H,57,71)(H,58,70)(H,59,66)(H,60,69)(H,61,68)(H,62,67)/t30-,31-,32+,41-,42-,43+,44-,45-/m0/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

PubMed
1.00E+3n/an/an/an/an/an/an/an/a



University of Pennsylvania

Curated by PDSP Ki Database




Mol Pharmacol 43: 838-44 (1993)


BindingDB Entry DOI: 10.7270/Q21N7ZN7
More data for this
Ligand-Target Pair